These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 18842333)

  • 1. Implication of the Akt2/survivin pathway as a critical target in paclitaxel treatment in human ovarian cancer cells.
    Weng D; Song X; Xing H; Ma X; Xia X; Weng Y; Zhou J; Xu G; Meng L; Zhu T; Wang S; Ma D
    Cancer Lett; 2009 Jan; 273(2):257-65. PubMed ID: 18842333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The abnormal expression of chromosomal region maintenance 1 (CRM1)-survivin axis in ovarian cancer and its related mechanisms regulating proliferation and apoptosis of ovarian cancer cells.
    Zhang J; Xu X; Chen Y; Guan X; Zhu H; Qi Y
    Bioengineered; 2022 Jan; 13(1):624-633. PubMed ID: 34898375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine kinase-2 silencing modulates sensitivity of HT-29 human colorectal cancer cells to paclitaxel-induced cell death through altering apoptosis-related proteins.
    Mu Y; Wang J; Li G
    Chem Biol Drug Des; 2023 Aug; 102(2):255-261. PubMed ID: 36929215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted reversal of multidrug resistance in ovarian cancer cells using exosome‑encapsulated tetramethylpyrazine.
    Zhao C; Qiu L; Wu D; Zhang M; Xia W; Lv H; Cheng L
    Mol Med Rep; 2024 Feb; 29(2):. PubMed ID: 38099342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statement of Retraction: The abnormal expression of chromosomal region maintenance 1 (CRM1)-survivin axis in ovarian cancer and its related mechanisms regulating proliferation and apoptosis of ovarian cancer cells.
    Bioengineered; 2024 Dec; 15(1):2299572. PubMed ID: 38376425
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Cross-species analysis of transcriptome emphasizes a critical role of TNF-α in mediating MAP2K7/AKT2 signaling in zearalenone-induced apoptosis" [J Hazard Mater 459 (2023) 132226].
    Zhang FL; Zhu KX; Wang JY; Zhang M; Yan JM; Liu QC; Zhang XY; Guo JC; Liu X; Sun QC; Ge W; Li L; Shen W
    J Hazard Mater; 2024 Apr; 467():133716. PubMed ID: 38355376
    [No Abstract]   [Full Text] [Related]  

  • 7. Integrative microRNA and gene expression analysis identifies new epigenetically regulated microRNAs mediating taxane resistance in ovarian cancer.
    Hassan MK; Waly AA; Elsayed W; Keshk S; Allam WR; El-Khamisy SF
    Sci Rep; 2021 Jan; 11(1):562. PubMed ID: 33436648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LHPP suppresses proliferation, migration, and invasion and promotes apoptosis in pancreatic cancer.
    Wu F; Chen Y; Zhu J
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32186702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emodin enhances antitumor effect of paclitaxel on human non-small-cell lung cancer cells in vitro and in vivo.
    Chen S; Zhang Z; Zhang J
    Drug Des Devel Ther; 2019; 13():1145-1153. PubMed ID: 31114158
    [No Abstract]   [Full Text] [Related]  

  • 10. Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer.
    Zhou B; Xu H; Xia M; Sun C; Li N; Guo E; Guo L; Shan W; Lu H; Wu Y; Li Y; Yang D; Weng D; Meng L; Hu J; Ma D; Chen G; Li K
    Front Med; 2017 Jun; 11(2):214-222. PubMed ID: 28470508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-shRNA vector enhances the silencing efficiency of exogenous and endogenous genes in human cells.
    Weng Y; Shi Y; Xia X; Zhou W; Wang H; Wang C
    Oncol Lett; 2017 Mar; 13(3):1553-1562. PubMed ID: 28454290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. let-7b and let-7c are determinants of intrinsic chemoresistance in renal cell carcinoma.
    Peng J; Mo R; Ma J; Fan J
    World J Surg Oncol; 2015 May; 13():175. PubMed ID: 25951903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aplysin sensitizes cancer cells to TRAIL by suppressing P38 MAPK/survivin pathway.
    Liu J; Ma L; Wu N; Liu G; Zheng L; Lin X
    Mar Drugs; 2014 Sep; 12(9):5072-88. PubMed ID: 25257790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose paclitaxel improves the therapeutic efficacy of recombinant adenovirus encoding CCL21 chemokine against murine cancer.
    Chen P; Luo S; Wen YJ; Li YH; Li J; Wang YS; Du LC; Zhang P; Tang J; Yang DB; Hu HZ; Zhao X; Wei YQ
    Cancer Sci; 2014 Nov; 105(11):1393-401. PubMed ID: 25230206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1-IRIS inactivation sensitizes ovarian tumors to cisplatin.
    Paul BT; Blanchard Z; Ridgway M; ElShamy WM
    Oncogene; 2015 Jun; 34(23):3036-52. PubMed ID: 25132263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenes associated with drug resistance in ovarian cancer.
    Liu X; Gao Y; Lu Y; Zhang J; Li L; Yin F
    J Cancer Res Clin Oncol; 2015 Mar; 141(3):381-95. PubMed ID: 24997551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse mechanisms of AKT pathway activation in human malignancy.
    Cheung M; Testa JR
    Curr Cancer Drug Targets; 2013 Mar; 13(3):234-44. PubMed ID: 23297823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer.
    Iida K; Zheng R; Shen R; Nanus DM
    Int J Oncol; 2012 Oct; 41(4):1192-8. PubMed ID: 22895534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dual PI3K/mTOR inhibitor NVP-BGT226 induces cell cycle arrest and regulates Survivin gene expression in human pancreatic cancer cell lines.
    Glienke W; Maute L; Wicht J; Bergmann L
    Tumour Biol; 2012 Jun; 33(3):757-65. PubMed ID: 22170433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer.
    Xia X; Ma Q; Li X; Ji T; Chen P; Xu H; Li K; Fang Y; Weng D; Weng Y; Liao S; Han Z; Liu R; Zhu T; Wang S; Xu G; Meng L; Zhou J; Ma D
    BMC Cancer; 2011 Sep; 11():399. PubMed ID: 21933447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.